0001571049-15-006091.txt : 20150731 0001571049-15-006091.hdr.sgml : 20150731 20150731210018 ACCESSION NUMBER: 0001571049-15-006091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150729 FILED AS OF DATE: 20150731 DATE AS OF CHANGE: 20150731 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BFI Co., LLC CENTRAL INDEX KEY: 0001601607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 151020721 BUSINESS ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 2013297300 MAIL ADDRESS: STREET 1: 300 FRANK W. BURR BLVD., STE 21 CITY: TEANECK STATE: NJ ZIP: 07666 4 1 t1501773_x1-bfi.xml OWNERSHIP DOCUMENT X0306 4 2015-07-29 0 0001069899 PHIBRO ANIMAL HEALTH CORP PAHC 0001601607 BFI Co., LLC 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 0 0 1 0 Class A Common Stock 2015-07-29 4 C 0 18000 A 84000 D Class A Common Stock 2015-07-29 4 S 0 6000 37.006 D 78000 D Class A Common Stock 2015-07-30 4 S 0 6000 38.007 D 72000 D Class A Common Stock 2015-07-31 4 S 0 8807 39.583 D 63193 D Class B Common Stock 2015-07-29 4 C 0 18000 D Class A Common Stock 18000 21247275 D The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.69 to $39.14, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.74 to $40.02, inclusive. /s/ Thomas G. Dagger, as Attorney-in-Fact for BFI Co., LLC 2015-07-31